Skip to main content
Equibles

STEPHENS INC /AR/

Position in HALO — Halozyme Therapeutics, Inc.

CIK 757657 LITTLE ROCK, AR
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$387,749
+$93,231 QoQ
Shares Held
4,954
+8.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#425
of 667 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. HALO ranks #8 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,900 $1,440,517
2 TECH
BIO-TECHNE Corp
 12,036 $850,343
3 TWST
Twist Bioscience Corp
 5,167 $531,580
4 REGN
Regeneron Pharmaceuticals, Inc.
 831 $518,161
5 LGND
Ligand Pharmaceuticals Inc
 1,625 $513,646
6 EXEL
Exelixis, Inc.
 9,079 $493,988
7 ALNY
Alnylam Pharmaceuticals, Inc.
 1,638 $493,087
8 HALO
Halozyme Therapeutics, Inc.
This page 		4,954 $387,749

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $387,749 4,954
2026-03-31 $294,518 4,557
2025-12-31 $273,372 4,062
2025-09-30 $304,874 4,157
2025-06-30 $270,868 5,207
2025-03-31 $347,828 5,451
2024-12-31 $261,233 5,464
2024-09-30 $391,578 6,841
2024-06-30 $480,821 9,183
2024-03-31 $375,028 9,219
2023-12-31 $232,441 6,289
2023-09-30 $234,166 6,130
2023-06-30 $211,911 5,875
2023-03-31 $111,591 2,922
2022-12-31 $164,953 2,899
2022-09-30 $114,626 2,899
2022-06-30 $127,556 2,899
2022-03-31 $115,612 2,899
2021-12-31 $101,731 2,530
2021-09-30 $102,920 2,530
2021-06-30 $114,887 2,530
2021-03-31 $105,475 2,530
2020-12-31 $22,636 530
2020-09-30 $82,335 3,133
2020-06-30 $107,240 4,000